Cargando…
Pharmacological cancer treatment and venous thromboembolism risk
Risk factors for cancer-associated thrombosis are commonly divided into three categories: patient-, cancer-, and treatment-related factors. Currently, different types of drugs are used in cancer treatment. Chemotherapy has been identified as an independent risk factor for venous thromboembolism (VTE...
Autores principales: | Muñoz Martín, Andrés J, Ramírez, Sara Pérez, Morán, Laura Ortega, Zamorano, Magdalena Ruiz, Benéitez, María Carmen Viñuela, Salcedo, Inmaculada Aparicio, Escobar, Ignacio García, Fernández, José Manuel Soria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189737/ https://www.ncbi.nlm.nih.gov/pubmed/32368194 http://dx.doi.org/10.1093/eurheartj/suaa004 |
Ejemplares similares
-
Application of Machine Learning to the Prediction of Cancer-Associated Venous Thromboembolism
por: Mantha, Simon, et al.
Publicado: (2023) -
Pharmacology of anticoagulants used in the treatment of venous thromboembolism
por: Nutescu, Edith A., et al.
Publicado: (2016) -
Erratum to: Pharmacology of anticoagulants used in the treatment of venous thromboembolism
por: Nutescu, Edith A., et al.
Publicado: (2016) -
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
por: Muñoz Martín, Andrés J., et al.
Publicado: (2018) -
Non pharmacological venous thromboembolism prophylaxis in old surgical patients
por: Apperti, M, et al.
Publicado: (2009)